Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Neurotherapeutics ; 19(6): 1942-1950, 2022 10.
Article in English | MEDLINE | ID: mdl-36129603

ABSTRACT

Hypothermia is a promising therapeutic strategy for severe vasospasm and other types of non-thrombotic cerebral ischemia, but its clinical application is limited by significant systemic side effects. We aimed to develop an intraventricular device for the controlled cooling of the cerebrospinal fluid, to produce a targeted hypothermia in the affected cerebral hemisphere with a minimal effect on systemic temperature. An intraventricular cooling device (acronym: V-COOL) was developed by in silico modelling, in vitro testing, and in vivo proof-of-concept application in healthy Wistar rats (n = 42). Cerebral cortical temperature, rectal temperature, and intracranial pressure were monitored at increasing flow rate (0.2 to 0.8 mL/min) and duration of application (10 to 60 min). Survival, neurological outcome, and MRI volumetric analysis of the ventricular system were assessed during the first 24 h. The V-COOL prototyping was designed to minimize extra-cranial heat transfer and intra-cranial pressure load. In vivo application of the V-COOL device produced a flow rate-dependent decrease in cerebral cortical temperature, without affecting systemic temperature. The target degree of cerebral cooling (- 3.0 °C) was obtained in 4.48 min at the flow rate of 0.4 mL/min, without significant changes in intracranial pressure. Survival and neurological outcome at 24 h showed no significant difference compared to sham-treated rats. MRI study showed a transient dilation of the ventricular system (+ 38%) in a subset of animals. The V-COOL technology provides an effective, rapid, selective, and safe cerebral cooling to a clinically relevant degree of - 3.0 °C.


Subject(s)
Hypothermia, Induced , Hypothermia , Animals , Rats , Body Temperature , Rats, Wistar , Bioengineering , Brain
2.
J Cereb Blood Flow Metab ; 37(10): 3344-3354, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28112023

ABSTRACT

Cerebral collaterals are dynamically recruited after arterial occlusion and highly affect tissue outcome in acute ischemic stroke. We investigated the efficacy and safety of four pathophysiologically distinct strategies for acute modulation of collateral flow (collateral therapeutics) in the rat stroke model of transient middle cerebral artery (MCA) occlusion. A composed randomization design was used to assign rats (n = 118) to receive phenylephrine (induced hypertension), polygeline (intravascular volume load), acetazolamide (cerebral arteriolar vasodilation), head down tilt (HDT) 15° (cerebral blood flow diversion), or no treatment, starting 30 min after MCA occlusion. Compared to untreated animals, treatment with collateral therapeutics was associated with lower infarct volumes (62% relative mean difference; 51.57 mm3 absolute mean difference; p < 0.001) and higher chance of good functional outcome (OR 4.58, p < 0.001). Collateral therapeutics acutely increased cerebral perfusion in the medial (+40.8%; p < 0.001) and lateral (+19.2%; p = 0.016) MCA territory compared to pretreatment during MCA occlusion. Safety indicators were treatment-related mortality and cardiorespiratory effects. The highest efficacy and safety profile was observed for HDT. Our findings suggest that acute modulation of cerebral collaterals is feasible and provides a tissue-saving effect in the hyperacute phase of ischemic stroke prior to recanalization therapy.


Subject(s)
Brain Ischemia/therapy , Cerebrovascular Circulation , Collateral Circulation/drug effects , Stroke/therapy , Animals , Head-Down Tilt/physiology , Infarction, Middle Cerebral Artery , Perfusion , Rats
3.
Viral Immunol ; 17(2): 279-86, 2004.
Article in English | MEDLINE | ID: mdl-15279705

ABSTRACT

Correlates of immune reconstitution after highly active antiretroviral therapy (HAART) are not completely understood, in particular as far as viro-immunological discordant responses are concerned. HIV-positive patients on stable HAART for > or = 1 year were recruited. Viro-immunological responses were categorized according to positive or negative area under the curve (AUC) variations for HIV plasma viral load (pVL) and CD4+ T-cell counts measured at least every 4 months. The following parameters were evaluated: lymphocyte spontaneous apoptosis (LSA), intracellular Bcl-2 expression in both CD4-CD45RA+ and CD4-CD45R0+, IL-7 and IL-15 plasma concentrations, and lymphocyte TRECs levels. Sixty-one patients were enrolled. A significant inverse correlation was found between CD4+ T-cell count and pVL AUC (r = 0.45; p = 0.0003). Patients with pVL response had higher levels of Bcl-2 in CD4-CD45R0+ (mean 65,409 MESF vs. 54,018 MESF; p = 0.089) and higher IL-15 (mean 1.34 pg/mL vs. 1.05 pg/mL; p = 0.069, respectively). Higher LSA and lower TRECs levels were found in viro-immunological non-responder patients with respect to those who had viro-immunological response (mean 24.84% vs. 14.89%; p = 0.01, and mean 17,796 copies/10(6) cells vs. 29,251 copies/10(6) cells; p = 0.68, respectively). Virological suppression may allow Bcl-2 and IL-15 hyperexpression during incomplete immune-reconstitution phase, while more complete immune reconstitution appeared to be marked by both high TRECs and low LSA levels, possibly indicating both central and peripheral CD4+ T-cell repopulations at this stage.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , HIV Infections/immunology , HIV Infections/virology , HIV-1/physiology , Adult , Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active , CD4-Positive T-Lymphocytes/drug effects , Female , HIV Infections/drug therapy , HIV-1/drug effects , Humans , Male , Viral Load
4.
AIDS Res Hum Retroviruses ; 19(12): 1079-82, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14709243

ABSTRACT

Among 165 HIV-infected patients, prevalence of SEN virus (SENV) infection was 51.5%, with subtype A predominance and unique SENV variant (67%), but also SENV superinfections with multiple variants were frequent. High prevalence, superinfection and broad SENV subtype diversification have been demonstrated, all linked to intravenous drug use (IVDU) as a risk factor for HIV acquisition. At multivariate analysis, SENV infection did not appear to have any negative impact on survival, while a possible protective effect needs further investigation.


Subject(s)
DNA Viruses/genetics , Disease Progression , HIV Infections/complications , Hepatitis, Viral, Human/virology , Substance Abuse, Intravenous/complications , Adult , DNA Viruses/classification , HIV Infections/pathology , Hepatitis, Viral, Human/complications , Hepatitis, Viral, Human/epidemiology , Humans , Male , Middle Aged , Prevalence
5.
Haematologica ; 89(4): 450-61, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15075079

ABSTRACT

BACKGROUND AND OBJECTIVES: In utero transplantation of hematopoietic stem cells allows immune reconstitution of fetuses with severe combined immunodeficiency. The objective of this work was to study the quality of T-cell reconstitution following this procedure. DESIGN AND METHODS: We evaluated the kinetics and extent of T-cell reconstitution in five infants with severe combined immune deficiency (SCID), three with a B+ and two with a B- phenotype, who received haploidentical stem cell transplantation before birth. To this end, we measured the frequency of T-cell receptor excision circles (TREC) and the diversity of the T-cell repertoire. RESULTS: In utero transplantation led to engraftment of donor-derived T lymphocytes which attained normal numbers in four infants, who are in good health. In the three patients with a B+ phenotype, generation of a heterogeneous T-cell repertoire was associated with development of TREC levels comparable to those of SCID patients treated by post-natal transplantation and of healthy babies. Of the two patients with a B- phenotype, one developed mixed T-cell chimerism and a substantial number of circulating T cells, associated with a variable heterogeneity of the T-cell repertoire; TREC levels were normal soon after birth, but declined thereafter. The remaining B- patient remained lymphopenic with a skewed T-cell repertoire and very low TREC levels. This patient eventually required transplantation from a matched unrelated donor at 5 years of age, but died of EBV-related lymphoproliferative disease. INTERPRETATION AND CONCLUSIONS: These data indicate that in utero transplantation of fetuses with B+ SCID allows generation of newly diversified T lymphocytes and ensures long-term reconstitution of cell-mediated immunity.


Subject(s)
Fetal Therapies , Hematopoietic Stem Cell Transplantation/methods , T-Lymphocytes/physiology , Adult , Female , Humans , Immune System/physiology , Infant , Pregnancy , Receptors, Antigen, T-Cell/genetics , Regeneration , Severe Combined Immunodeficiency/therapy , Thymus Gland/physiology
6.
Clin Lab ; 49(3-4): 123-7, 2003.
Article in English | MEDLINE | ID: mdl-12705693

ABSTRACT

Since it has been demonstrated that concomitant infections could influence the outcome of antiviral treatment, we investigated whether the presence of SENV infection may interfere with highly active antiretroviral therapy (HAART) in HIV+ coinfected patients. In spite of persistent fluctuations in SENV-A positivity we could not find any correlation between SENV-DNA and the immunological and virologic parameters found in the patients, suggesting SENV has no apparent clinical relevance during highly active antiretroviral therapy.


Subject(s)
Antiretroviral Therapy, Highly Active , Circoviridae Infections/complications , HIV Infections/drug therapy , Circoviridae/genetics , Circoviridae/isolation & purification , Circoviridae Infections/virology , DNA, Viral/blood , Female , HIV Infections/complications , Humans , Male , Middle Aged
7.
Clin Immunol ; 121(2): 203-14, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16962827

ABSTRACT

Common variable immunodeficiency disease (CVID) is a primary immune disorder affecting B cells and characterized by hypogammaglobulinemia and recurrent infections. To elucidate the clinical and immunological heterogeneity of this condition, we have studied B and T cell subsets in 25 CVID patients. In eleven of them, we observed a remarkable relative expansion of a B cell subpopulation (CD19(hi)/CD21(lo) cells) characterized by the absence of CD23 and the reduced expression of the chemokine receptors CXCR5 and CCR7. Our analyses demonstrated in these patients that the expansion of CD19(hi)/CD21(lo) cells correlates with a selective decrease of circulating naïve and CD21(hi) memory B lymphocytes. The same group of patients displayed a simultaneous severe reduction of naïve CD4+ T cells associated with decreased levels of T cell receptor excision circles. These observations suggest that a combined defect in generation of B and T subpopulations may account for the abnormal immunophenotype characterizing this subgroup of CVID patients.


Subject(s)
Agammaglobulinemia/immunology , B-Lymphocyte Subsets/immunology , Common Variable Immunodeficiency/immunology , T-Lymphocyte Subsets/immunology , Adolescent , Adult , Agammaglobulinemia/blood , Antigens, CD19/blood , Case-Control Studies , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Receptors, CCR7 , Receptors, CXCR5 , Receptors, Chemokine/blood , Receptors, Complement 3d/blood
8.
Intervirology ; 48(4): 216-22, 2005.
Article in English | MEDLINE | ID: mdl-15920345

ABSTRACT

OBJECTIVE: The SEN virus (SENV) represents a recently described group of DNA viruses, two members of which (SENV-D and SENV-H) are linked with posttransfusion hepatitis. Since patients on hemodialysis have a high risk of being infected by blood-borne viruses, we investigated the prevalence of seven SENV isolates in two distinct units of our hospital. METHODS: The presence of SENV was investigated in 171 hemodialysis patients and in 163 controls by using a polymerase chain reaction based methodology, with which the specificity of amplified products was detected by hybridization with probes specific for each variant. Polymerase chain reaction products from 4 patients were sequenced. RESULTS: The overall detection of SENV DNA as well as of SENV-D, SENV-E, and SENV-G was significantly higher in one of the two units, and there was a higher degree of homology in the sequences prepared from patients of the same unit. Furthermore, we demonstrated that mixed infections with multiple SENV were common. No relationship was observed between presence of SENV and sex, age, duration of hemodialysis, previous transfusions or transplantation, hepatitis infection, and routine liver test results. CONCLUSION: Our results indicate that patients who undergo hemodialysis can be at high risk of SENV transmission and suggest an intraunit transmission of specific SENV variants.


Subject(s)
Circoviridae Infections/epidemiology , Circoviridae/classification , Cross Infection/epidemiology , Genetic Variation , Renal Dialysis/adverse effects , Aged , Aged, 80 and over , Circoviridae/genetics , Circoviridae/isolation & purification , Circoviridae Infections/transmission , Circoviridae Infections/virology , Cross Infection/transmission , Cross Infection/virology , DNA, Viral/analysis , DNA, Viral/blood , Female , Humans , Male , Middle Aged , Polymerase Chain Reaction , Prevalence , Sequence Analysis, DNA
9.
Immunogenetics ; 56(3): 214-9, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15138733

ABSTRACT

Like the immunoglobulin genes, the T-cell receptor genes are generated by rearrangements of non-contiguous genomic V, D and J regions, but unlike the immunoglobulin genes, somatic hypermutation is an infrequent event in T-cell receptor genes. Here, we describe the occurrence of spontaneous mutations in the constant regions of the T-cell receptor beta chains of T lymphocytes obtained from two babies who underwent in utero transplantation because of severe combined immunodeficiency. In view of the fact that in babies receiving transplants before birth, hematopoietic chimerism is consistently present, the lymphocytes are likely to be under chronic activation, which may represent a relevant biologic stimulus for generating the observed T-cell receptor hypermutation. This possibility is supported by the finding that the highest number of mutations was identified in clonally expanded T cells. These results provide further support indicating that hypermutation of the T-cell receptor genes may indeed occur, given the necessary conditions.


Subject(s)
Genes, T-Cell Receptor beta , Immunoglobulin Constant Regions/genetics , Mutation , Receptors, Antigen, T-Cell, alpha-beta/genetics , Adult , Amino Acid Sequence , Base Sequence , Female , Fetus/surgery , Gene Frequency , Hematopoietic Stem Cell Transplantation , Humans , Infant , Male , Molecular Sequence Data , Pregnancy , Receptors, Antigen, T-Cell, alpha-beta/chemistry , Sequence Alignment , Severe Combined Immunodeficiency/surgery , Uterus
10.
J Med Virol ; 68(1): 18-23, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12210426

ABSTRACT

The prevalence, route of transmission, and clinical significance of SEN virus (SENV) infection was evaluated in 715 samples obtained from 150 blood donors, 165 patients infected by HIV, 150 with HCV/HBV infection, 80 with autoimmune diseases, 40 with Primary Immunodeficiency, 40 with sexually transmitted diseases, 40 polytransfused, and from 50 unselected patients. The identification of SENV-DNA was performed by polymerase chain reaction and hybridization, followed by an immunoenzymatic method that identify different SENV strains. SENV-A variant is largely represented among HIV-infected patients, being found in 71% of HIV(+) intravenous drug users and in 26% of individuals that had acquired HIV through sex. A high prevalence of SENV-A was observed also in HIV- polytransfused (27%) or in patients with sexually transmitted diseases (30%). These percentages are significantly higher than those observed in an unselected population and in blood donors. Prevalence of SENV-A is, therefore, high among HIV(+) patients with parental risk of exposure, but this infection does not appear to influence the clinical or immune status of HIV(+) patients.


Subject(s)
DNA Viruses/genetics , Genetic Variation , HIV Infections/complications , Hepatitis, Viral, Human/virology , Substance Abuse, Intravenous/complications , Adult , DNA Viruses/classification , Female , Hepatitis, Viral, Human/epidemiology , Humans , Male , Prevalence
11.
J Med Virol ; 66(3): 421-7, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11793397

ABSTRACT

Sera from 30 women at high risk for infection, one half of which were SEN virus positive (SENV(+)), were collected at delivery to study SENV mother-to child transmission. Thirteen of their babies were positive for at least one SENV strain: one baby was SENV(+) at birth, eight became positive within 6 months from delivery, and four became positive in the following months. Our data indicate that vertical transmission of SENV does occur, presumably, at delivery, but it may not induce persistent viremia. This is supported by the fact that, generally, SENV is not detected at birth, by the high SENV homology in the sequences found in the mothers and in their children, by a lack of other risk factors for infection of the babies, and by the irregular detection of SENV in the follow-up. No clinical events surely linked to SENV infection were found, but transient elevations of alanine aminotransferase were observed in babies followed for a long period of time.


Subject(s)
DNA Virus Infections/virology , DNA Viruses/genetics , Infectious Disease Transmission, Vertical , DNA Virus Infections/blood , DNA Virus Infections/transmission , DNA Viruses/classification , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Mothers , Phylogeny
12.
Intervirology ; 47(6): 350-4, 2004.
Article in English | MEDLINE | ID: mdl-15564747

ABSTRACT

SEN virus (SENV) is a new family of single-stranded DNA viruses with eight different strains, A-H. The modifications in SENV DNA detection and subtype distribution were studied over a long-term follow-up (48 +/- 32.5 months) in 52 HIV-infected patients. 46% of the patients in the first sample and 34.6% in the second sample were found to have detectable SENV viremia. While the most prevalent variant in the first sample was found to be genotype A (83.3%), the second sample revealed a broader subtype diversification. Several epidemiological and clinical variables were tested in univariate model for clearance of detectable SENV viremia, but none of them reached statistical significance. In conclusion, a high degree of instability of both SENV DNA detection and subtype distribution in a cohort of HIV-infected patients was suggested, which may have important implications for further studies on both SENV epidemiology and its clinical impact.


Subject(s)
Circoviridae/isolation & purification , DNA, Viral/analysis , HIV Infections/complications , Adult , Circoviridae/genetics , Cohort Studies , Female , HIV Infections/pathology , Humans , Male , Prospective Studies
13.
Blood ; 104(2): 444-52, 2004 Jul 15.
Article in English | MEDLINE | ID: mdl-15026312

ABSTRACT

The chemokine receptor CXCR4 and its functional ligand, CXCL12, are essential regulators of development and homeostasis of hematopoietic and lymphoid organs. Heterozygous truncating mutations in the CXCR4 intracellular tail cause a rare genetic disease known as WHIM syndrome (warts, hypogammaglobulinemia, infections, myelokathexis), whose pathophysiology remains unclear. We report CXCR4 function in 3 patients with WHIM syndrome carrying heterozygous truncating mutations of CXCR4. We show that CXCR4 gene mutations in WHIM patients do not affect cell surface expression of the chemokine receptor and its internalization upon stimulation with CXCL12. Moreover, no significant differences in calcium mobilization in response to CXCL12 are found. However, the chemotactic response of both polymorphonuclear cells and T lymphocytes in response to CXCL12 is increased. Furthermore, immunophenotypic analysis of circulating T and B lymphocytes reveals a decreased number of memory B cells and of naive T cells and an accumulation of effector memory T cells associated with a restricted T-cell repertoire. Based on our results, we suggest that the altered leukocyte response to CXCL12 may account for the pathologic retention of mature polymorphonuclear cells in the bone marrow (myelokathexis) and for an altered lymphocyte trafficking, which may cause the immunophenotyping abnormalities observed in WHIM patients.


Subject(s)
Agammaglobulinemia/immunology , Bacterial Infections/immunology , Chemokines, CXC/genetics , Neutropenia/immunology , Warts/immunology , Adolescent , Adult , Agammaglobulinemia/genetics , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Bacterial Infections/genetics , Bone Marrow/immunology , Calcium/metabolism , Chemokine CXCL12 , Child , DNA Mutational Analysis , Female , Flow Cytometry , Gene Expression/immunology , Humans , Immunophenotyping , Neutropenia/genetics , Neutrophils/cytology , Neutrophils/immunology , Syndrome , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Warts/genetics
SELECTION OF CITATIONS
SEARCH DETAIL